Germline mutation in the TP53 gene in uveal melanoma

被引:0
|
作者
Nikola Hajkova
Jan Hojny
Kristyna Nemejcova
Pavel Dundr
Jan Ulrych
Katerina Jirsova
Johana Glezgova
Ivana Ticha
机构
[1] Charles University and General University Hospital in Prague,Institute of Pathology, First Faculty of Medicine
[2] Charles University and General University Hospital in Prague,1st Department of Surgery – Department of Abdominal, Thoracic Surgery and Traumatology, First Faculty of Medicine
[3] Charles University and General University Hospital in Prague,Clinic of Pediatrics and Adolescent Medicine, First Faculty of Medicine
[4] Charles University and General University Hospital in Prague,Department of Ophthalmology, First Faculty of Medicine
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
We performed comprehensive molecular analysis of five cases of metastasizing uveal malignant melanoma (UM) (fresh-frozen samples) with an NGS panel of 73 genes. A likely pathogenic germline TP53 mutation c.760A > G (p.I254V) was found in two tumor samples and matched nontumor tissue. In three cases, pathogenic BAP1 mutation was detected together with germline missense variants of uncertain significance in ATM. All cases carried recurrent activating GNAQ or GNA11 mutation. Moreover, we analyzed samples from another 16 patients with primary UM by direct Sanger sequencing focusing only on TP53 coding region. No other germline TP53 mutation was detected in these samples. Germline TP53 mutation, usually associated with Li-Fraumeni syndrome, is a rare event in UM. To the best of our knowledge, only one family with germline TP53 mutation has previously been described. In our study, we detected TP53 mutation in two patients without known family relationship. The identification of germline aberrations in TP53 or BAP1 is important to identify patients with Li-Fraumeni syndrome or BAP1 cancer syndrome, which is also crucial for proper genetic counseling.
引用
收藏
相关论文
共 50 条
  • [21] Case Report of an Unusual Tumor in an Adult With a TP53 Germline Mutation
    Castiaux, Julie
    Vandernoot, Isabelle
    Dallemagne, Julie
    Bruneau, Marie
    Delaunoy, Melanie
    Peyrassol, Xavier
    Heimann, Pierre
    De Wilde, Virginie
    Wolfromm, Alice
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 (08): : E645 - E648
  • [22] Report of a bi-allelic truncating germline mutation in TP53
    Brown, Natasha J.
    Bhatia, Kanika
    Teague, Julie
    White, Susan M.
    Lo, Patrick
    Challis, Jackie
    Beshay, Victoria
    Sullivan, Michael
    Malkin, David
    Hansford, Jordan R.
    FAMILIAL CANCER, 2019, 18 (01) : 101 - 104
  • [23] The TP53 gene promoter is not methylated in families suggestive of Li-Fraumeni syndrome with no germline TP53 mutations
    Finkova, Alena
    Vazna, Alzbeta
    Hrachovina, Ondrej
    Bendova, Sarka
    Prochazkova, Kamila
    Sedlacek, Zdenek
    CANCER GENETICS AND CYTOGENETICS, 2009, 193 (01) : 63 - 66
  • [24] Mutation and function of TP53
    Milner, J
    BRAIN PATHOLOGY, 2000, 10 (04) : 504 - 504
  • [25] The TP53 website: an integrative resource centre for the TP53 mutation database and TP53 mutant analysis
    Leroy, Bernard
    Fournier, Jean Louis
    Ishioka, Chikashi
    Monti, Paola
    Inga, Alberto
    Fronza, Gilberto
    Soussi, Thierry
    NUCLEIC ACIDS RESEARCH, 2013, 41 (D1) : D962 - D969
  • [26] REMISSION OF AML IN A PATIENT WITH GERMLINE TP53 MUTATION AFTER DECITABINE MONOTHERAPY
    Sadanand, Arhanti
    Qayed, Muna
    Keller, Frank
    PEDIATRIC BLOOD & CANCER, 2022, 69
  • [27] A NOVEL GERMLINE TP53 MUTATION IN A PATIENT WITH LI-FRAUMENI SYNDROME
    Douglass, David
    Farrar, Jason
    Stine, Kimo
    PEDIATRIC BLOOD & CANCER, 2019, 66
  • [28] Gray Zone Lymphoma Arising in the Neck of a Teenager With a Germline Mutation in TP53
    Gatineau-Sailliant, Sophie
    Turcotte, Karine
    Quintal, Marie-Claude
    Turpin, Sophie
    Champagne, Josette
    Petrella, Tony
    Roussy, Mathieu
    Cellot, Sonia
    Bouron-Dal Soglio, Dorothee
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2019, 41 (06) : E405 - E408
  • [29] TP53 Action and the Consequences of TP53 Mutation in Acute Myeloid Leukemia
    Lowe, Scott W.
    BLOOD, 2019, 134
  • [30] Germline TP53 Variants and Susceptibility to Osteosarcoma
    Mirabello, Lisa
    Yeager, Meredith
    Mai, Phuong L.
    Gastier-Foster, Julie M.
    Gorlick, Richard
    Khanna, Chand
    Patino-Garcia, Ana
    Sierrasesumaga, Luis
    Lecanda, Fernando
    Andrulis, Irene L.
    Wunder, Jay S.
    Gokgoz, Nalan
    Barkauskas, Donald A.
    Zhang, Xijun
    Vogt, Aurelie
    Jones, Kristine
    Boland, Joseph F.
    Chanock, Stephen J.
    Savage, Sharon A.
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2015, 107 (07):